Photo credit: NovaSight

By  Mallory Hackett 12:18 pm March 16, 2021
Today NovaSight, an Israeli digital eye treatment and assessment startup in the pediatric space, announced a clinical trial for its CureSight system, with the goal of achieving Food and Drug Administration 510(k) clearance. CureSight presents a new treatment method for amblyopia, also known as lazy eye, that doesn’t require patching. The device trains the brain to use both eyes simultaneously...

Credit: NovaSight

By  Sara Mageit 08:46 am July 14, 2020
Israel-based startup specialising in AI vision care, NovaSight, has announced that it has finalised its round A financing totalling $8 million. The round was led by venture capital firm, Rimonci Capital and joined by strategic investors from both pharmaceutical and medical device industries. Prior to this round, the company raised $8 million for a total of $16 million. WHY IT MATTERS The funds...